Encouraged by the promising data, the present study aims to investigate (1) the relationship between four core structures and their antiproliferative activities towards both AR-positive (LNCaP) and AR-null (PC-3 and DU-145) prostate cancer cell lines. This evidence concerns the gene AR and prostate carcinoma.